Skip to Main Content

Paper Details

Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer.
Nat Med
966
2018
Epstein-, Epstein-Barr virus, Epstein-Barr virus-positive tumors, PD, PD-1, PD-L1, circulating tumor DNA, ctDNA, gastric cancer, mGC, metastatic gastric cancer, patients, programmed cell death 1, programmed death-ligand 1, tumors
Author NameAffiliation
Sung Tae KimSamsung Medical Center, Sungkyunkwan University School of Medicine
Sung Tae KimSamsung Medical Center, Sungkyunkwan University School of Medicine
Adam J BassDana-Farber Cancer Institute
Kyoung-Mee KimSamsung Medical Center, Sungkyunkwan University School of Medicine
Kyung KimSamsung Medical Center, Sungkyunkwan University School of Medicine
Joon Oh ParkSamsung Medical Center, Sungkyunkwan University School of Medicine
Min Gew ChoiSamsung Medical Center, Sungkyunkwan University School of Medicine
AmirAli Talasaz
Andrey LobodaMerck & Co., Inc.
Jeeyun LeeSamsung Medical Center, Sungkyunkwan University School of Medicine
  • 1 - 10

Datasets

Release 1.2